CH423095A - Verfahren zur Herstellung eines Tollwutimpfstoffes - Google Patents

Verfahren zur Herstellung eines Tollwutimpfstoffes

Info

Publication number
CH423095A
CH423095A CH21163A CH21163A CH423095A CH 423095 A CH423095 A CH 423095A CH 21163 A CH21163 A CH 21163A CH 21163 A CH21163 A CH 21163A CH 423095 A CH423095 A CH 423095A
Authority
CH
Switzerland
Prior art keywords
virus
vaccine
dependent
cells
medium
Prior art date
Application number
CH21163A
Other languages
German (de)
English (en)
Inventor
Roberts Sharpless George
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of CH423095A publication Critical patent/CH423095A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B11/00—Preservation of milk or dairy products
    • A23B11/10—Preservation of milk or milk preparations
    • A23B11/12—Preservation of milk or milk preparations by heating
    • A23B11/13—Preservation of milk or milk preparations by heating the materials being loose unpacked
    • A23B11/133—Preservation of milk or milk preparations by heating the materials being loose unpacked and progressively transported through the apparatus
    • A23B11/137—Preservation of milk or milk preparations by heating the materials being loose unpacked and progressively transported through the apparatus in direct contact with the heating medium, e.g. steam
    • A23B11/1375—Preservation of milk or milk preparations by heating the materials being loose unpacked and progressively transported through the apparatus in direct contact with the heating medium, e.g. steam by pulverisation of the milk, including free falling film
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CH21163A 1962-01-10 1963-01-09 Verfahren zur Herstellung eines Tollwutimpfstoffes CH423095A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US165298A US3156620A (en) 1962-01-10 1962-01-10 Attenuated live rabies vaccine and method of preparing the same

Publications (1)

Publication Number Publication Date
CH423095A true CH423095A (de) 1966-10-31

Family

ID=22598325

Family Applications (1)

Application Number Title Priority Date Filing Date
CH21163A CH423095A (de) 1962-01-10 1963-01-09 Verfahren zur Herstellung eines Tollwutimpfstoffes

Country Status (5)

Country Link
US (1) US3156620A (en:Method)
BR (1) BR6345841D0 (en:Method)
CH (1) CH423095A (en:Method)
FR (2) FR1604109A (en:Method)
GB (1) GB958344A (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0101285A3 (en) * 1982-08-09 1987-04-08 Koken Co. Ltd. A substratum for cell culture and a method using it

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3435117A (en) * 1966-03-09 1969-03-25 Ethicon Inc Collagen fibril matrix pharmaceuticals
US3469003A (en) * 1966-04-01 1969-09-23 Haver Lockhart Lab Inc Injectable reconstituted collagen fluid adjuvant for vaccines and other drugs
US4147772A (en) * 1976-02-03 1979-04-03 Merck & Co., Inc. Vaccine stabilizer
DE2816349A1 (de) * 1978-04-14 1979-10-25 Merck & Co Inc Vaccinstabilisator
CH638985A5 (de) * 1979-04-10 1983-10-31 Schweiz Serum & Impfinst Verfahren zur herstellung eines tollwutimpfstoffes und danach erhaltener impfstoff.
US4338335A (en) * 1980-02-05 1982-07-06 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
JPS5832876B2 (ja) * 1981-03-27 1983-07-15 呉羽化学工業株式会社 組織培養基材
US4537769A (en) * 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2773800A (en) * 1953-04-28 1956-12-11 Lilly Co Eli Rabies vaccine production
US2768114A (en) * 1953-08-21 1956-10-23 American Cyanamid Co Rabies vaccines and methods of preparing the same
US2915436A (en) * 1955-04-11 1959-12-01 Allied Lab Inc Process for the attenuation of infectious canine hepatitis virus and a vaccine prepared therefrom
US2912361A (en) * 1956-11-28 1959-11-10 Sterling Drug Inc Canine distemper vaccine and its preparation
US3000788A (en) * 1958-05-15 1961-09-19 Dow Chemical Co Propagation of modified infectious canine hepatitis virus in tissue cultures of pig kidney and the preparation of a vaccine therefrom
US2965544A (en) * 1959-02-24 1960-12-20 American Cyanamid Co Tissue culture propagated canine distemper virus and vaccine thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0101285A3 (en) * 1982-08-09 1987-04-08 Koken Co. Ltd. A substratum for cell culture and a method using it

Also Published As

Publication number Publication date
GB958344A (en) 1964-05-21
US3156620A (en) 1964-11-10
FR1604109A (en) 1971-07-12
FR3055M (en:Method) 1965-01-11
BR6345841D0 (pt) 1973-06-14

Similar Documents

Publication Publication Date Title
DE2817891A1 (de) Nd-impfstoff und verfahren zu seiner herstellung
DE2708668A1 (de) Nd-impfstoff und verfahren zu seiner herstellung
CH423095A (de) Verfahren zur Herstellung eines Tollwutimpfstoffes
CH658192A5 (de) Tollwut-impfstoff und verfahren zu seiner herstellung.
DE1198489B (de) Verfahren zur Herstellung eines Impfstoffes gegen Panleucopenie
DE2425997A1 (de) Verfahren zur herstellung von abgeschwaechtem katzenfiebervakzin
DE1617397A1 (de) Verfahren zur Herstellung eines tumorstatisch wirkenden Mittels
DE1950774A1 (de) Heteroploide Zellinien
DE2058645C2 (de) Verfahren zur Herstellung eines stark abgeschwächten Newcastle-Disease-Virus-Lebendimpfstoffs
DE841333C (de) Verfahren zur Herstellung von Bakterienpraeparaten von Treponema Pallidum
DE2050945A1 (de) Verfahren zum Zuchten lebensfähiger Staphylococcus Bakterien zur Erzeugung einer Antivirus Substanz
DE191752C (en:Method)
DE2165401C3 (de) Inaktivierter Kombinationsimpfstoff zum Immunisieren von Geflügel gegen Infektion der Atmungsorgane
DE2162013C3 (de) Tollwut-Lebendimpfstoff, Verfahren zu seiner Herstellung nd seine Verwendung bei der Bekämpfung von Tollwut
DE940315C (de) Verfahren zur Herstellung von Lymphe gegen Schweinepest
AT96830B (de) Verfahren zur Herstellung eines Nährbodens für Influenzabazillen und zur Herstellung von Impfstoffen aus diesen.
DE1258547B (de) Verfahren zur Herstellung eines Tollwut-Impfstoffes
DE1617549C (de) Verfahren zur Herstellung eines Impf Stoffs gegen Tollwut
AT234902B (de) Verfahren zur Herstellung einer Vaccine gegen Staupe
DE1467849A1 (de) Verfahren zur Herstellung von Vakzinen
DE424197C (de) Verfahren zur Herstellung eines Naehrbodens fuer Influenzabazillen und zur Herstellung von Impfstoffen aus diesen
DE1617548C3 (de) Verfahren zur Herstellung eines Impfstoffs gegen die Maul- und Klauenseuche
DE1021128B (de) Verfahren zur Herstellung eines Impfstoffes gegen die Rhinotracheitis der Rinder
AT257050B (de) Verfahren zur Herstellung von BCG-Vaccinen
AT117206B (de) Verfahren zur Herstellung von Impfstoffen.